Home  »  Hot Stocks   »  A Lesson to Learn: China Pharma Holdings Inc. (CPH...

A Lesson to Learn: China Pharma Holdings Inc. (CPHI)

China Pharma Holdings Inc. (AMEX:CPHI) went up by 8.31% from its latest closing price compared to the recent 1-year high of $0.53. The company’s stock price has collected 7.01% of gains in the last five trading sessions.

Is It Worth Investing in China Pharma Holdings Inc. (AMEX :CPHI) Right Now?

Plus, the 36-month beta value for CPHI is at 0.46. Opinions of the stock are interesting as 1 analysts out of 1 who provided ratings for China Pharma Holdings Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

The average price from analysts is $4.50. CPHI currently public float of 23.36M and currently shorts hold a 1.05% ratio of that float. Today, the average trading volume of CPHI was 2.38M shares.

CPHI’s Market Performance

CPHI stocks went up by 7.01% for the week, with a monthly drop of -1.61% and a quarterly performance of -16.55%, while its annual performance rate touched -68.22%. The volatility ratio for the week stands at 10.47% while the volatility levels for the past 30 days are set at 12.20% for China Pharma Holdings Inc. The simple moving average for the period of the last 20 days is 9.42% for CPHI stocks with a simple moving average of -37.65% for the last 200 days.

Analysts’ Opinion of CPHI

Many brokerage firms have already submitted their reports for CPHI stocks, with Rodman & Renshaw repeating the rating for CPHI by listing it as a “Mkt Outperform.” The predicted price for CPHI in the upcoming period, according to Rodman & Renshaw is $6 based on the research report published on January 08th of the previous year 2010.

CPHI Trading at 3.77% from the 50-Day Moving Average

After a stumble in the market that brought CPHI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -77.95% of loss for the given period.

Volatility was left at 12.20%, however, over the last 30 days, the volatility rate increased by 10.47%, as shares sank -1.69% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +9.02% upper at present.

During the last 5 trading sessions, CPHI rose by +7.01%, which changed the moving average for the period of 200-days by -68.73% in comparison to the 20-day moving average, which settled at $0.1059. In addition, China Pharma Holdings Inc. saw 20.96% in overturn over a single year, with a tendency to cut further gains.

Stock Fundamentals for CPHI

Current profitability levels for the company are sitting at:

  • -29.67 for the present operating margin
  • +3.23 for the gross margin

The net margin for China Pharma Holdings Inc. stands at -35.26. Equity return is now at value -81.00, with -19.00 for asset returns.

The liquidity ratio also appears to be rather interesting for investors as it stands at 0.86.

Here’s Our Rant About Coty Inc. (COTY)

Coty Inc. (NYSE:COTY) went up by 1.37% from its latest closing price compared to the recent 1-year high of $10.31. The company’s stock price has